chr21-46602608-G-T

Variant summary

Our verdict is Benign. The variant received -12 ACMG points: 0P and 12B. BP4_StrongBA1

The ENST00000397648.1(S100B):​c.-193C>A variant causes a 5 prime UTR change involving the alteration of a non-conserved nucleotide. The variant allele was found at a frequency of 0.0299 in 541,620 control chromosomes in the GnomAD database, including 1,110 homozygotes. In-silico tool predicts a benign outcome for this variant. No clinical diagnostic laboratories have submitted clinical-significance assessments for this variant to ClinVar.

Frequency

Genomes: 𝑓 0.061 ( 741 hom., cov: 33)
Exomes 𝑓: 0.018 ( 369 hom. )

Consequence

S100B
ENST00000397648.1 5_prime_UTR

Scores

2

Clinical Significance

Not reported in ClinVar

Conservation

PhyloP100: -0.319

Publications

5 publications found
Variant links:
Genes affected
S100B (HGNC:10500): (S100 calcium binding protein B) The protein encoded by this gene is a member of the S100 family of proteins containing 2 EF-hand calcium-binding motifs. S100 proteins are localized in the cytoplasm and/or nucleus of a wide range of cells, and involved in the regulation of a number of cellular processes such as cell cycle progression and differentiation. S100 genes include at least 13 members which are located as a cluster on chromosome 1q21; however, this gene is located at 21q22.3. This protein may function in Neurite extension, proliferation of melanoma cells, stimulation of Ca2+ fluxes, inhibition of PKC-mediated phosphorylation, astrocytosis and axonal proliferation, and inhibition of microtubule assembly. Chromosomal rearrangements and altered expression of this gene have been implicated in several neurological, neoplastic, and other types of diseases, including Alzheimer's disease, Down's syndrome, epilepsy, amyotrophic lateral sclerosis, melanoma, and type I diabetes. [provided by RefSeq, Jul 2008]

Genome browser will be placed here

ACMG classification

Classification was made for transcript

Our verdict: Benign. The variant received -12 ACMG points.

BP4
Computational evidence support a benign effect (BayesDel_noAF=-0.95).
BA1
GnomAd4 highest subpopulation (AFR) allele frequency at 95% confidence interval = 0.183 is higher than 0.05.

Transcripts

RefSeq

Gene Transcript HGVSc HGVSp Effect Exon rank MANE Protein UniProt
S100BNM_006272.3 linkc.-1-192C>A intron_variant Intron 1 of 2 ENST00000291700.9 NP_006263.1 P04271A0A0S2Z4C5
S100BXM_017028424.3 linkc.-8-185C>A intron_variant Intron 1 of 2 XP_016883913.1 P04271A0A0S2Z4C5

Ensembl

Gene Transcript HGVSc HGVSp Effect Exon rank TSL MANE Protein Appris UniProt
S100BENST00000397648.1 linkc.-193C>A 5_prime_UTR_variant Exon 1 of 2 1 ENSP00000380769.1 P04271
S100BENST00000291700.9 linkc.-1-192C>A intron_variant Intron 1 of 2 1 NM_006272.3 ENSP00000291700.4 P04271
S100BENST00000367071.4 linkc.-1-192C>A intron_variant Intron 1 of 3 1 ENSP00000356038.4 A8MRB1

Frequencies

GnomAD3 genomes
AF:
0.0607
AC:
9234
AN:
152036
Hom.:
735
Cov.:
33
show subpopulations
Gnomad AFR
AF:
0.187
Gnomad AMI
AF:
0.00
Gnomad AMR
AF:
0.0267
Gnomad ASJ
AF:
0.00317
Gnomad EAS
AF:
0.00443
Gnomad SAS
AF:
0.108
Gnomad FIN
AF:
0.0203
Gnomad MID
AF:
0.0506
Gnomad NFE
AF:
0.00329
Gnomad OTH
AF:
0.0502
GnomAD4 exome
AF:
0.0178
AC:
6941
AN:
389466
Hom.:
369
Cov.:
5
AF XY:
0.0205
AC XY:
4199
AN XY:
204372
show subpopulations
African (AFR)
AF:
0.183
AC:
1981
AN:
10812
American (AMR)
AF:
0.0208
AC:
255
AN:
12278
Ashkenazi Jewish (ASJ)
AF:
0.00301
AC:
36
AN:
11970
East Asian (EAS)
AF:
0.00108
AC:
29
AN:
26902
South Asian (SAS)
AF:
0.0860
AC:
2766
AN:
32162
European-Finnish (FIN)
AF:
0.0170
AC:
416
AN:
24516
Middle Eastern (MID)
AF:
0.0292
AC:
52
AN:
1780
European-Non Finnish (NFE)
AF:
0.00335
AC:
825
AN:
246430
Other (OTH)
AF:
0.0257
AC:
581
AN:
22616
Allele Balance Distribution
Red line indicates average allele balance
Average allele balance: 0.508
Heterozygous variant carriers
0
289
578
866
1155
1444
0.00
0.20
0.40
0.60
0.80
0.95
Allele balance

Age Distribution

Exome Het
Exome Hom
Variant carriers
0
56
112
168
224
280
<30
30-35
35-40
40-45
45-50
50-55
55-60
60-65
65-70
70-75
75-80
>80
Age
GnomAD4 genome
AF:
0.0609
AC:
9259
AN:
152154
Hom.:
741
Cov.:
33
AF XY:
0.0613
AC XY:
4562
AN XY:
74400
show subpopulations
African (AFR)
AF:
0.186
AC:
7722
AN:
41460
American (AMR)
AF:
0.0266
AC:
407
AN:
15288
Ashkenazi Jewish (ASJ)
AF:
0.00317
AC:
11
AN:
3470
East Asian (EAS)
AF:
0.00444
AC:
23
AN:
5184
South Asian (SAS)
AF:
0.108
AC:
522
AN:
4824
European-Finnish (FIN)
AF:
0.0203
AC:
215
AN:
10596
Middle Eastern (MID)
AF:
0.0612
AC:
18
AN:
294
European-Non Finnish (NFE)
AF:
0.00329
AC:
224
AN:
68014
Other (OTH)
AF:
0.0554
AC:
117
AN:
2112
Allele Balance Distribution
Red line indicates average allele balance
Average allele balance: 0.504
Heterozygous variant carriers
0
388
776
1164
1552
1940
0.00
0.20
0.40
0.60
0.80
0.95
Allele balance

Age Distribution

Genome Het
Genome Hom
Variant carriers
0
98
196
294
392
490
<30
30-35
35-40
40-45
45-50
50-55
55-60
60-65
65-70
70-75
75-80
>80
Age
Alfa
AF:
0.00256
Hom.:
1
Bravo
AF:
0.0647

ClinVar

Not reported in ClinVar

Computational scores

Source: dbNSFP v4.3

Name
Calibrated prediction
Score
Prediction
BayesDel_noAF
Benign
-0.95
CADD
Benign
0.44
DANN
Benign
0.50
PhyloP100
-0.32
PromoterAI
-0.066
Neutral
Mutation Taster
=100/0
polymorphism (auto)

Splicing

Name
Calibrated prediction
Score
Prediction
SpliceAI score (max)
0.0
Details are displayed if max score is > 0.2

Find out detailed SpliceAI scores and Pangolin per-transcript scores at spliceailookup.broadinstitute.org

Publications

Other links and lift over

dbSNP: rs11911834; hg19: chr21-48022521; COSMIC: COSV52452904; API